Evidence map›Paper›PMID 34221265›Full record

ArticleGastroenterology and hepatology from bed to bench2021

Cost-effectiveness analysis of two routine therapeutic methods for

Farhad Pourfarzi, Telma Zahirian Moghadam, Hamed Zandian, Reza Malekzadeh, Abbas Yazdanbod

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Gastroenterology and hepatology from bed to bench, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. An Update on Eradication ofMiddle East journal of digestive diseases · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Farhad PourfarziDigestive Diseases Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Telma Zahirian MoghadamSocial Determinants of Health Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Hamed ZandianSocial Determinants of Health Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Reza MalekzadehDigestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences School of Commerce, Tehran, Iran.
Abbas YazdanbodDigestive Diseases Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Ardabil University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis study aimed to analyze the cost-effectiveness of two routine therapeutic methods for

backgroundBecause of the importance of

methodsThis cross-sectional study was conducted on 7,496 participants with positive Hepadnaviridae (HPsAg) test results for

resultsThe total direct cost of

conclusionBased on the results, furazolidone was more cost-effective than clarithromycin for

Indexed as

ClarithromycinCost-effectivenessEradicationFurazolidoneHelicobacter pylori

Identifiers

PMID34221265
PMCPMC8245840
OpenAlexW3175206350

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.